Gerrit Borchard is a licensed pharmacist and obtained his Ph.D. in pharmaceutical technology from the University of Frankfurt (Germany). After holding several academic positions at Saarland (Germany) and at Leiden University (The Netherlands), he joined Enzon Pharmaceuticals, Inc. (USA) as Vice President Research. In 2005, he was appointed Full Professor of Biopharmaceutics at the University of Geneva (Switzerland), and in 2015, he was an invited professor at Graz University (Austria).

Since 2014, he is president of the Swiss Academy of Pharmaceutical Sciences (SAPhS). In 2012 he joined the Non Biological Complex Drugs (NBCD) working group hosted at Lygature (Utrecht, The Netherlands), joining its steering committee in 2015. He was nominated Chair of the NBCD working party at the European Directorate for the Quality of Medicines & Health Care (EDQM) by Swissmedic and joined the External Advisory board of the EU-Nanotechnology Characterization Laboratory (EU-NCL) in 2016. In January 2019 he was appointed to the steering board of contactpointnano.ch, a platform fostering SMEs in the field of nanomedicine in Switzerland.

Having been exposed to a variety of different work environments, he became fluent in the Dutch, English, French and German languages. Being an enthusiastic long-distance runner, he loves to roam the trails and by-roads of the Swiss mountains.